|
0
|
|
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
(linkinghub.elsevier.com)
|
Li JJ
…
Zhi-Ming Shao
Cell Reports Medicine
2026-08-06
|
#breast cancer
#precision medicine
#neoadjuvant
#classification
#subtyping
|
|
0
|
|
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
(linkinghub.elsevier.com)
|
Bui TBV
…
Rosenbluth JM
Cell Reports Medicine
2026-08-06
|
#breast cancer
#organoid
#biomarker
#precision medicine
#drug resistance
|
|
0
|
|
Filling the holes in whole genomes: A vision for personalized genomics from telomere to telomere.
(linkinghub.elsevier.com)
|
Phillippy AM
…
Miga KH
Cell
2026-08-06
|
#genomics
#sequencing
#diagnostics
#precision medicine
|
|
0
|
|
A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.
(nature.com)
|
Bahl S
…
Lupien M
Nature Communications
2026-08-06
|
#cancer
#transcriptomics
#chromatin
#precision medicine
#drug sensitivity
|